The epidemiology of sepsis in the United States from 1979 through 2000

被引:4497
作者
Martin, GS
Mannino, DM
Eaton, S
Moss, M
机构
[1] Emory Univ, Sch Med, Dept Med, Div Pulm Allergy & Crit Care, Atlanta, GA USA
[2] Ctr Dis Control & Prevent, Natl Ctr Environm Hlth, Atlanta, GA USA
关键词
D O I
10.1056/NEJMoa022139
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
BACKGROUND: Sepsis represents a substantial health care burden, and there is limited epidemiologic information about the demography of sepsis or about the temporal changes in its incidence and outcome. We investigated the epidemiology of sepsis in the United States, with specific examination of race and sex, causative organisms, the disposition of patients, and the incidence and outcome. METHODS: We analyzed the occurrence of sepsis from 1979 through 2000 using a nationally representative sample of all nonfederal acute care hospitals in the United States. Data on new cases were obtained from hospital discharge records coded according to the International Classification of Diseases, Ninth Revision, Clinical Modification. RESULTS: Review of discharge data on approximately 750 million hospitalizations in the United States over the 22-year period identified 10,319,418 cases of sepsis. Sepsis was more common among men than among women (mean annual relative risk, 1.28 [95 percent confidence interval, 1.24 to 1.32]) and among nonwhite persons than among white persons (mean annual relative risk, 1.90 [95 percent confidence interval, 1.81 to 2.00]). Between 1979 and 2000, there was an annualized increase in the incidence of sepsis of 8.7 percent, from about 164,000 cases (82.7 per 100,000 population) to nearly 660,000 cases (240.4 per 100,000 population). The rate of sepsis due to fungal organisms increased by 207 percent, with gram-positive bacteria becoming the predominant pathogens after 1987. The total in-hospital mortality rate fell from 27.8 percent during the period from 1979 through 1984 to 17.9 percent during the period from 1995 through 2000, yet the total number of deaths continued to increase. Mortality was highest among black men. Organ failure contributed cumulatively to mortality, with temporal improvements in survival among patients with fewer than three failing organs. The average length of the hospital stay decreased, and the rate of discharge to nonacute care medical facilities increased. CONCLUSIONS: The incidence of sepsis and the number of sepsis-related deaths are increasing, although the overall mortality rate among patients with sepsis is declining. There are also disparities among races and between men and women in the incidence of sepsis. Gram-positive bacteria and fungal organisms are increasingly common causes of sepsis.
引用
收藏
页码:1546 / 1554
页数:9
相关论文
共 49 条
  • [1] Reduced mortality in association with the acute respiratory distress syndrome (ARDS)
    Abel, SJC
    Finney, SJ
    Brett, SJ
    Keogh, BF
    Morgan, CJ
    Evans, TW
    [J]. THORAX, 1998, 53 (04) : 292 - 294
  • [2] Consensus conference definitions for sepsis, septic shock, acute lung injury, and acute respiratory distress syndrome: Time for a reevaluation
    Abraham, E
    Matthay, MA
    Dinarello, CA
    Vincent, JL
    Cohen, J
    Opal, SM
    Glauser, M
    Parsons, P
    Fisher, CJ
    Repine, JE
    [J]. CRITICAL CARE MEDICINE, 2000, 28 (01) : 232 - 235
  • [3] ALCOHOL-RELATED HOSPITALIZATIONS OF ELDERLY PEOPLE - PREVALENCE AND GEOGRAPHIC-VARIATION IN THE UNITED-STATES
    ADAMS, WL
    YUAN, Z
    BARBORIAK, JJ
    RIMM, AA
    [J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1993, 270 (10): : 1222 - 1225
  • [4] ADAMS WL, 1993, JAMA-J AM MED ASSOC, V270, P2055
  • [5] Epidemiology of sepsis and infection in ICU patients from an international multicentre cohort study
    Alberti, C
    Brun-Buisson, C
    Burchardi, H
    Martin, C
    Goodman, S
    Artigas, A
    Sicignano, A
    Palazzo, M
    Moreno, R
    Boulmé, R
    Lepage, E
    Le Gall, JR
    [J]. INTENSIVE CARE MEDICINE, 2002, 28 (02) : 108 - 121
  • [6] Epidemiology of sepsis and infection in ICU patients from an international multicentre cohort study (vol 28, pg 108, 2002)
    Alberti, C
    Brun-Buisson, C
    Burchardi, H
    Martin, C
    Goodman, S
    Artigas, A
    Sicignano, A
    Palazzo, M
    Moreno, R
    Boulmé, R
    Lepage, E
    Le Gall, JR
    [J]. INTENSIVE CARE MEDICINE, 2002, 28 (04) : 525 - 526
  • [7] Epidemiology of severe sepsis in the United States: Analysis of incidence, outcome, and associated costs of care
    Angus, DC
    Linde-Zwirble, WT
    Lidicker, J
    Clermont, G
    Carcillo, J
    Pinsky, MR
    [J]. CRITICAL CARE MEDICINE, 2001, 29 (07) : 1303 - 1310
  • [8] E5 murine monoclonal antiendotoxin antibody in gram-negative sepsis - A randomized controlled trial
    Angus, DC
    Birmingham, MC
    Balk, RA
    Scannon, PJ
    Collins, D
    Kruse, JA
    Graham, DR
    Dedhia, HV
    Homann, S
    MacIntyre, N
    [J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2000, 283 (13): : 1723 - 1730
  • [9] BECKSAGUE CM, 1993, J INFECT DIS, V167, P1247, DOI 10.1093/infdis/167.5.1247
  • [10] Efficacy and safety of recombinant human activated protein C for severe sepsis.
    Bernard, GR
    Vincent, JL
    Laterre, P
    LaRosa, SP
    Dhainaut, JF
    Lopez-Rodriguez, A
    Steingrub, JS
    Garber, GE
    Helterbrand, JD
    Ely, EW
    Fisher, CJ
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2001, 344 (10) : 699 - 709